DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy
Journal article published in 2004 by
J. L. Schultze 
,
M. S. von Bergwelt-Baildon,
S. Grabbe,
M. Vonbergweltbaildon
,
M. S. von Bergwelt-Baildon,
S. Grabbe,
M. Vonbergweltbaildon
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 